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Molecular characterization and analysis of the biosynthetic gene 
cluster for the antitumor antibiotic mitomycin C from 
Streptomyces lawendulae NRRL 2564 
Yingqing Mao, Mustafa Varoglu and David H Sherman 
Background: The mitomycins are natural products that contain a variety of 
functional groups, including aminobenzoquinone- and aziridine-ring systems. 
Mitomycin C (MC) was the first recognized bioreductive alkylating agent, and 
has been widely used clinically for antitumor therapy. Precursor-feeding 
studies showed that MC is derived from 3-amino-5-hydroxybenzoic acid 
(AHBA), D-glucosamine, L-methionine and carbamoyl phosphate. A genetically 
linked AHBA biosynthetic gene and MC resistance genes were identified 
previously in the MC producer Streptomyces lavendulae NRRL 2564. We set 
out to identify other genes involved in MC biosynthesis. 
Results: A cluster of 47 genes spanning 55 kilobases of S. lavendulae DNA 
governs MC biosynthesis. Fourteen of 22 disruption mutants did not express 
or overexpressed MC. Seven gene products probably assemble the AHBA 
intermediate through a variant of the shikimate pathway. The gene encoding 
the first presumed enzyme in AHBA biosynthesis is not, however, linked 
within the MC cluster. Candidate genes for mitosane nucleus formation and 
functionalization were identified. A putative MC translocase was identified 
that comprises a novel drug-binding and export system, which confers cellular 
self-protection on S. lavendulae. Two regulatory genes were also identified. 
Conclusions: The overall architecture of the MC biosynthetic gene cluster in 
S. lavendulae has been determined. Targeted manipulation of a putative MC 
pathway regulator led to a substantial increase in drug production. The 
cloned genes should help elucidate the molecular basis for creation of the 
mitosane ring system, as well efforts to engineer the biosynthesis of novel 
natural products. 
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Introduction 
Since its discovery and demonstration of anticancer activ- 
ity in the 196Os, many aspects of the chemistry and 
biology of mitomycin C (MC) have been investigated. 
This has provided detailed information on the unprece- 
dented molecular mechanism, unique biological and phar- 
macological properties, drug resistance and bioactive 
analogues of MC [l,Z]. MC is regarded as the prototype 
natural-product alkylating agent whose activity is depen- 
dent on reductive activation (either chemically, such as 
low pH, or enzymatically, such as DT-diaphorase or 
NADH cytochrome c reductase) [3,4]. Activated 1lC: 
cross-links double-stranded DNA, which in turn induces 
diverse biological effects including selective inhibition of 
DNA synthesis, mutagenesis, induction of DNA repair 
(SOS response), sister-chromatid exchange, signal trans- 
duction and induction of apoptosis [S]. Tumor hypoxia 
and the increased expression of bioreductive enz)-mes in 
malignant cells create a selective environment for drug 
activation and make MC an attractive agent for antitumor 
therapy [6]. MC remains a clinically important component 
of combination cancer chemotherapy and radiotherapy of 
solid tumors [7]. 
In addition to its biological and pharmacological impor- 
tance, MC is prominent because its molecular mechanism 
represents a model for structurally related antitumor 
antibiotics porfiromycin [8], mitiromycin [9], FR66979 
[lo], FR900482 [ll], FK973 [12], and FK317 [13], as well 
as structurally unrelated bioreductive agents such as E09 
[14] and tirapazamine [15]. Numerous MC derivatives 
have been synthesized and tested for enhanced activities. 
including the recently identified selective protein tyrosine 
kinase inhibitor, la-docosahexaenoyl MC: [16,17]. 
MC is derived, in part, from 3-amino-5hydroxybenzoic 
acid (AHAA), a precursor that is also required for biosyn- 
thesis of ansamycin antibiotics, including rifamycin 
[l&19]. Incorporation experiments with radiolabeled pre- 
cursors have demonstrated that the mitosane core of MC 
is derived from the junction of AHRA and D-glucosamine 
[20,21] (Figure 1). The O- and LV- (but not C-) methyl 
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groups were shown to be derived from I,-methionine, and 
the C-10 carbamoyl group originates from L-arginine or 
L-citrulline [ZZ-241. 
MC has been an important synthetic target, in addition to 
being the subject of numerous studies to understand its 
mechanism of activation and DNA alkylation. Little is 
k nown, however, about the details of its convergent 
assembly from AHBA and u-glucosamine in Streptom~~s 
lavena’us’ae. Understanding the derivation of AHBA is 
important to determine if cde rzo~ biosynthesis of MC is 
related to the primary metabolic shikimate pathway, an 
important route in microorganisms and plants for aromatic 
amino-acid biosynthesis [ZS]. Another intriguing question 
involves the details of cellular self-protection in S. laven- 
a’dae because the preferred MC alkylation sites in DNA 
are guanine and cytosine, and MC-induced cell death can 
result from a single cross-link per genome [26]. 
To address the above questions, the MC AHB.A synthase 
(v&A) and two MC resistance genes (muA and rrrra’) were 
cloned from S. lavenchlae, and mrd was found to be 
closely linked to m&l [27-291. We therefore set out to 
clone and sequence the large cluster of genes adjoining 
mitA that encode MC structural, regulatory and resis- 
tance components. This work provides the first direct 
genetic information about the biosynthesis of this clini- 
cally important antitumor antibiotic, and provides the 
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foundation for dissecting further the function of individ- 
ual genes and enzymes involved in assembly of mitosane 
natural products. 
Results 
Identification of the mitomycin biosynthetic gene cluster 
(MC cluster) 
The MC cluster was identified by linkage of a cosmid 
clone containing rnr~! and a gene (m&) that hybridized 
with the rlfli gene encoding the rifamycin AHBA synthase 
[30] from Amycolatopsis mediterranei. m&l was subse- 
quently shown to be essential for hlC biosynthesis 
because genetic disruption of the chromosomal copy 
blocked MC production, and could be complemented 
with exogenous AHBA [29]. Linkage of mitil with one of 
the 1lC resistance genes (mra’l implied that the corre- 
sponding biosynthetic genes were adjacent to m&l. In this 
work, cosmid walking was used to obtain overlapping 
DNA fragments spanning more than 120 kilobases of the 
S. lavendulae chromosome adjacent to rtzd. Subsequent 
nucleotide sequence analysis included 55 kb of contigu- 
ous DNA, revealing 47 genes involved in hlC assembly, 
regulation and resistance (Tables 1 and 2; Figure 2). 
mitT defines the left-hand boundary of the MC cluster 
Nucleotide-sequence analysis extended 30 kb down- 
stream of mid and revealed a set of genes corresponding 
to a type 1 polyketide synthase (PKS: of9, ~$8) and a 
thioesterase (TEII; ofl). MC is not derived from the 
polyketide pathway-an ofl8 disruption mutant showed 
normal MC production as expected (Table 2). Approxi- 
mately 20 kb downstream of rnz%, two genes (mitT and 
mid’) encoding a putative aminoquinate dehydrogenase 
and a kinase, respectively, were located. Both are believed 
to be involved in AHB,4 biosynthesis because their equiv- 
alents are also present in the rifamycin biosynthetic gene 
cluster (rifcluster) [31]. Whether the six genes between 
ofl and mitT are involved in MC biosynthesis remained 
unclear, however, because the two putative hydroxylases 
(oti?, ofl4) and the candidate activator gene to@) could 
conceivably play a role in MC production. Both o?f? and 
od4 are predicted to encode cytochrome P450 monooxy- 
genases with Orf4 most similar to OleP and RapN (50% 
identity, 63% similarity) involved in oleandomycin and 
rapamycin biosynthesis, respectively [32,33]. Orf3 shows a 
high degree of similarity to cytochrome Pd.50 10X1 (49% 
identity, 64% similarity) in Streptomyces sp. and 
cytochrome P4.50-SUZ in Streptomycps griseohs [34,35]. 
Database analysis revealed that Orfl belonged to the ActII- 
ORF4, RedD, DnrI and CcaR family of Streptomyes antibi- 
otic pathway specific activators regulating the production of 
actinorhodin, undecylprodigiosin, daunorubicin and 
cephamycin, respectively [3-O]. A common feature of this 
group of activators is that disruption of the corresponding 
gene abolishes production of the corresponding antibiotic, 
whereas overexpression results in a several-fold increase in 
metabolite production. When o@ was disrupted, however, 
the mutant strain showed normal ?JC production (Table 2). 
Moreoverl the wild-type MC producer containing an addi- 
tional copy of o@ in pKC1139 also had a normal hlC pro- 
duction profile (Table 2). Interesting&-, 0$4, one of the 
cytochrome P450 monooxygenase encoding genes adjacent 
to orf2 also showed normal hlC production when disrupted 
(Table 2). mitT, therefore, appears to map to the left-hand 
end of the hlC cluster. whereas ~f-o@9 presumably 
specify biosynthesis of an unidentified polyketide product. 
mmcY defines the right-hand boundary of the MC cluster 
Nucleotide-sequence analysis of the hlC biosynthetic gene 
cluster extended 30 kb upstream of mid and several open- 
reading frames (orfs) corresponding to genes involved in 
sugar metabolism \vere identified. They included an acid 
trehalase (orfl-l), one ABC-type transporter (a$Z6), and 
four adjacent a-amylases (o@Y, otf20, o#Z’l and 0322) for 
starch degradation spanning more than 18 kb (Figure 2). 
Disruption of four genes (o$f. ollf/l, or;f16 and orjI9) 
within this region resulted in mutants with wild-type level 
MC production profiles, indicating that they fall outside of 
the MC cluster (Table 2). At the beginning of this group of 
sugar metabolism genes. a gene (mmcy) encoding a pre- 
sumed chitinase is proposed to be the upstream terminus 
of the hlC cluster. This is evident because hlC requires 
u-glucosamine as a biosynthetic precursor. and Mmc\r 
shows 75% identity (85% similarity) to the chitinase C 
gene (rhiC) product from S. griseus that generates ;V-acetyl- 
glucosamine from chitin [41]. In addition. mutants with 
disrupted o$ll and wfl.? genes had no effect on hlC pro- 
duction, whereas disruption of mm~M’ and mmcX both 
affected MC production significantly (Table 2). 
MC resistance genes 
Antibiotic biosynthetic gene clusters typically include one 
or more genes for cellular self-protection [42]. Previous 
work has identified two mitomycin C resistance genes (mrr 
and IN~U’) with ~UZ’ linked to m&i (27-291. Subsequent 
analysis showed that \lrd is a resistance protein that binds 
mitomycin C with 1:l stoichiometry [28]. However. this 
resistance mechanism would be extremely inefficient 
unless the bound drug is transported out of the cell. Indeed, 
5 kb upstream of nzrd, the m/r gene (a putative MC translo- 
case) encoding a presumed antibiotic transporter was found 
and shown to be a third MC resistance component [WI. met 
encodes a 484 amino-acid protein with 14 predicted trans- 
membrane domains. Disruption of m-r resulted in a mutant 
S. hvena’zdae strain substantially &ore sensitive to MC, and 
coexpression of mtt with mrt/ in Esderkhia ro/,li dramatically 
increased MC resistance levels compared with individual 
expression of the genes [43]. In contrast, the high-level MC 
resistance gene (md), which encodes an MC oxidase 
(hIcrA) capable of re-oxidizing activated hlC [44], is not 
linked with this cluster [27,29]. Interestingly, database 
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Table 1 
Deduced genes and their proposed functions in the MC cluster. 
Gene Amino acids 
Accession numbers of 
homologous proteins 
Typical homology 
(‘J/o identity, O/o similarity) Proposed function 
orf6 414 
orf5 176 
off4 407 
orf3 410 
orf2 368 
orfl 285 
mitT 270 
mitS 315 
mitR 514 
mitQ 164 
mitf 343 
mit0 163 
mitN 275 
mitM 283 
mitL 520 
mitK 346 
mitJ 235 
mitl 290 
mitH 382 
mitG 404 
mitF 257 
mitE 707 
mitD 383 
mitC 260 
mitB 272 
mitA 388 
mmcA 514 
mmcB 93 
mmcC 470 
mmcD 611 
mmcE 359 
mmcF 145 
mmcG 177 
mmcH 254 
mmcl 264 
mmcJ 274 
mmcK 460 
mmcL 511 
mmcM 472 
mmcN 395 
mmc0 474 
mrd 130 
mmcf 443 
mm& 123 
mmcR 351 
mmcS 546 
mmcT 568 
mm& 160 
mmcV 319 
met 484 
mmcW 163 
mmcX 413 
mmcY 271 
orfl 1 139 
orfl2 936 
1020391,3114701 (540/o, 740/o) 
2496757,2104395 (380/o, 57%) 
99020,117302 (47%, 66%) 
561882,987105 (51%, 63%) 
1552858,1502425 (38%, 54%) 
118783,1168271 (390/o, 45%) 
2792323,2492956 (560/o, 67%) 
2792326,729585 (53%, 63%) 
1170892,3282517 (260/o, 33%) 
152404,2982999 (430/o, 500/o) 
3056886,2792321 (700/o, 77%) 
2791588 (32%, 48%) 
2792343,2246452 (32%, 48%) 
2792343,1001725 (400/o, 49%) 
1502425,1552858 (280/o, 42%) 
2826429, 2129143 (369’0, 51 O/o) 
2792325,3056884 (640/o, 750/o) 
2129143,2826429 (40”/0,490/0) 
3056883 (460/o, 61 o/o) 
1841491,2506147 (390/o, 51 O/o) 
1040685,665920 (31 O/o, 520/o) 
2648528,1806159 (22%, 39%) 
2894171 (540/o, 620/o) 
1314568,1651894 (36%, 43%) 
2147019,995684 (670/o, 76%) 
2984024,113194 (29%,61 O/O) 
2622915,3131076 (340/o, 53%) 
2622160,2506843 (360/o, 560/o) 
2792346,1703004 (740/o, 81 O/o) 
2105061,2829569 (36%,50%) 
1568583,2649391 (550/o, 69%) 
2829504,2735505 (36%, 47%) 
3218385 (28%, 46%) 
2829486,2228233 (43%, 6 1 o/o) 
1170892,3282517 (54%, 69%) 
117302,2147740 (370/o, 560/o) 
1917021 
396392,2851659 (380/o, 600/o) 
1169359,730913 (400/o, 58%) 
2498662,3328168 (45%, 58%) 
730909,769829 (38%, 55%) 
1652032,2650349 (52%, 69%) 
1706266,882645 (67%, 81 o/o) 
282580,2995318 (52%, 66%) 
1172058,127291 (390/o, 54%) 
2662299,116329 (75%,85%) 
2879888 (390/o, 58%) 
1061284, 1352001 (42%, 57%) 
Dehydrogenase 
LinA homolog 
Cytochrome P450 hydroxylase 
Cytochrome P450 hydroxylase 
Esterase 
Transcriptional activator 
aminoauinate Dehydrogenase (Rifl homolog) 
Kinase (RifN homolog) 
McrA Homolog 
Putative regulator 
aminoDHCl Synthase (RifG homolog) 
Unknown 
Methyltransferase 
Methyltransferase 
Esterase 
F420-dependent H,MPT reductase 
Phosphatase (RifM homolog) 
Unknown 
F420-dependent H4MPT reductase 
Oxidoreductase (RifL homolog) 
Reductase 
CoA ligase 
Unknown 
Unknown 
Glycosyltransferase 
AHBA synthase (RifK homolog) 
Unknown 
Acyl carrier protein 
Unknown 
Methyltransferase 
H4MPT:CoM Methyltransferase 
aminoDHCI Dehydratase (RifJ homolog) 
Unknown 
Unknown 
F420-dependent H4MPT reductase 
F420-dependent H4MPT reductase 
Unknown 
Aldehyde dehydrogenase 
McrA homolog 
Cytochrome P450 hydroxylase 
Unknown 
Mitomycin resistance determinant (Mrd) 
Unknown 
Unknown 
0-Methyltransferase 
Carbamoyl transferase 
Hydroxylase 
Sulfate adenylate transferase unit I 
Sulfate adenylate transferase unit II 
Mitomycin C translocase (Met) 
Repressor 
Unknown 
Chitinase 
Unknown 
Acid trehalase 
searches identified two McrA homologs (MitR and MmcM) similarity), whereas MmcM shows end-to-end (54% iden- 
within the MC cluster, both of which encode putative flavo- tity, 69% similarity) alignment with the protein. mitR and 
proteins conserved in the FMN/FAD binding motif. MitR mmcM were genetically disrupted resulting in substantially 
displayed weak similarity to McrA (26% indentity, 33% decreased MC production in the mitR mutant strain, in 
Research Paper Mitomycin C biosynthetic gene cluster Mao, Varoglu and Sherman 255 
Table 2 
MC production in wild type S. /even&&e and gene-disruption 
mutants. 
Number Gene disrupted MC production 
0.0 
0.1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
Wild-type control 
Additional copy of orfl in wild type 
orf8 
off4 
Ol-fl 
mitR 
mitM 
mitl 
mitH 
mitE 
mitB 
miti 
mmcA 
mmcB 
mmcM 
mm& 
mmcR 
mmcT 
mmcW 
mm& 
Off11 
orfl2 
orfl6 
or179 
++ 
++ 
++ 
++ 
++ 
+ 
++, normal MC production; -1 no MC production; +, reduced MC 
producfion; ++++, increased MC producfion. 
contrast to the mmcM mutant, which displayed wild-type 
MC production levels (Table 2). 
Regulatory genes 
Two genes (tn;ty and mmcW) were identified in the MC 
cluster and are presumed to be pathway-specific regula- 
tors. MitQ belongs to the OmpR-PhoB subfamily of DNA 
binding regulators in the two-component regulatory 
system, with the greatest similarity to members of the 
phosphate assimilation pathway (PhoR-PhoB) [45]. ferric 
enterobactin response pair (PfeR-PfeS) [46], and one his- 
tidine protein kinase-response regulator system (HpkPI- 
DrrA) from Thermotoga maritima 1471. In contrast to the 
MitQ group of regulators that typically serve as transcrip- 
tional activators [48], XlmcW shared high sequence simi- 
larity with the hlarR group of repressors. The most 
significant similarity corresponds to EmrR, the negative 
regulator of the E. coli multidrug resistance pump EmrAB 
[49], and PecS a repressor for pectinase, cellulase and blue 
pigment production in Eminia c/zql.cQzt/ietni [SO]. Signifi- 
cantly, the mm&’ disruption mutant displayed a several- 
fold increase in MC production (Table 2). 
AHBA biosynthetic genes 
Precursor-incorporation studies previously demonstrated 
that AHBA is an intermediate for both the ansamycin 
and mitomycin natural products [l&29]. Combining the 
biochemical, enzymatic and tnolecular genetic results on 
the biosynthesis of the ansamycin antibiotic rifamycin, 
Floss and coworkers [Sl] have proposed that AHBA is 
derived from the ammoniated shikimate pathway via 
phosphoenolpyruvate (PEP) and erythrose l-phosphate 
(E4P) by the early incorporation of nitrogen. In the shiki- 
tnate pathway, PEP and E4P is first converted to 3-deoxy- 
I>-arabino-heptulosonic acid-7-phosphate (DAHP) then 
stepwise transformed to 3-dehydroquinate (DHQ), 
3-dehydroshikimate (DHS) and shikitnate. catalyzed by 
DAHP synthase, DHQ synthase, DHQ dchydratase and 
shikimate dehydrogenase. respectively [52]. Quinate can 
also enter the pathway through the action of quinate dehy- 
drogenase to generate DHQ. Evidence to support this 
new variant of the shikimate pathway includes the follow- 
ing experimental observations. First, all proposed ammo- 
niated shikimate pathway compounds, including PEP, 
E4P, 3,4-dideoxy-4-amino-r,-arabino-heptuiosonic acid 
7-phosphate (aminoDAHP), 5deoxy-.5-amino-3-dehydro- 
quinic acid (aminoDHQ), and S-deoxy-5amino-3-dehy- 
droshikimic acid (aminoDHS), can be readily converted 
into AHBA by cell-free extrncts from the ansamycin pro- 
ducers, whereas none of the early shikimate pathway 
intermediates, DAHP. DHQ, DHS, quinic acid or 
shikimic acid, can be incorporated into AHBA under the 
same conditions [21,51]. Second, the r‘ifcluster has been 
sequenced, and all of the genes encoding early shikimate 
pathwa>- enzymes are found within the cluster [31]. 
Finally, the ability of the rifamycin AHBA synthase (RifK) 
to catalyze dehydration of aminoDHS to AHBA has been 
demonstrated previously [30]. Our work has also shown 
that the AHBA synthase gene (m&I) in S. favendulae is 
required for AHBA biosynthesis [29]. 
A group of AHBA biosynthetic genes similar to those 
described for rifhave been identified in the MC cluster. In 
addition to AHBA synthase, six gene products in the MC 
cluster showed high sequence similarity (over 43% identity) 
with their rifamycin AHBA biosynthetic gene homologs. 
These gene products include aminoDHQ synthase (MitP, 
RifG equivalent), aminoyuinate dehydrogenase (MitT, RifI 
equivalent), oxidoreductase (MitG, RifL equivalent), phos- 
phatase (MitJ, RinI equivalent), kinase (MitS, RifN equiv- 
alent) and aminoDHQ dehydratase (MmcF, RifJ 
equivalent). In addition to the significant sequence similar- 
ity to rifamycin counterparts, all three putative hlC shiki- 
mate pathway enzymes displayed significant alignment 
with microbial prima? shikimate metabolic enzymes 
including MitT with the quinate dehydrogenase (AroE) 
from :W~t/lcmoroc~z4s;~~~nn.~~~ii (28% identity, 46% similarity) 
[.53], MitP with the DHQ synthase (AroB) from A@vbac- 
tt~-illm tuhercu/usis (46% identity, 61% similarity) [54], and 
MmcF with the DHQ dehydratase frotn S. coeholor (SO% 
identity. 62% similarity) [Xl. Despite extensive sequenc- 
ing of 15 kb on either side of the mapped right- and left- 
hand ends of the \lC cluster, an aminoD,4HP synthase 
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Figure 2 
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gene corresponding to RifH (the proposed first enzyme in 
the de noao biosynthesis from PEP and E4P in the r;f 
cluster), was not found (Figure 2). Interestingly, a r$H 
homolog has been cloned from 8. la~endulae genomic DNA 
through Southern hybridization and shown to be unlinked 
to the MC cluster (Y&l., unpublished observations). 
The existence of the nonshikimate-pathway-related phos- 
phatase/kinase pair in the MC cluster (MitJMtS) and the 
$ cluster (RifM/RifN) further support the finding that 
these two genes are required for AHBA biosynthesis [25]. 
In addition to the strong homology to Rifhl, MitJ also 
showed 56% identity (69% similarity) with ORFX from the 
ansamycin antibiotic ansamitocin producer Actinosyznema 
pretdosum auranticum. Other polypeptides with consider- 
able sequence similarity belong to the CBBY family of 
phosphoglycolate phosphatases in glycolate oxidation [Xl. 
MitS, most similar to RifN (53% identity, 63% similarity), 
also showed significant similarity with the glucose kinase 
(involved in glucose repression) from S. coelicolor and 
Bacilhs megaterium [57,.58]. miG’, the third nonshikimate- 
pathway-related AHBA biosynthetic gene in this cluster is 
also worthy of note because it shows exclusive similarity 
(46% identity, 61% similarity) with oxidoreductase RifI, 
and its equivalent in Adnoqnnema pretiosum aurantirum. 
The detailed function of these gene products in AHBA 
biosynthesis remains to be elucidated. 
Mitosane-formation genes 
Precursor-incorporation studies established that the 
mitosane core is assembled from the condensation of 
AHBA and n-glucosamine [20,21,2-l]. Although no specific 
Research Paper Mitomycin C biosynthetic gene cluster Mao, Varoglu and Sherman 257 
gene products can be assigned for forming the three bonds 
bridging AHBA and I>-glucosamine, two genes downstream 
of mitA (r&B and mitE) probably encode enzymes that 
mediate one of these reactions. h/IitB shows local sequence 
similarity with a group of glycosyltransferases involved in 
glycopeptide antibiotic and polysaccharide biosynthesis, 
the typical function of which is to attach an activated sugar 
residue to a core compound [29,.59]. MitE has weak similar- 
ity (22% identity and 45% similarity) to the two cloned 
3-hydroxybenzoate-CoA ligases from Rhodopseud~montrs.~ 
pa/u&s involved in the anaerobic degradation of aromatic 
compounds [60]. h,IitE also showed similarity to a group of 
long-chain fatty acid Copl Iigases, as well as to the O-suc- 
cinylbenzoic acid CoA synthetase in Wtamin K2 biosynthe- 
sis [61]. mitB and mitE disruption mutants both have an 
hlC-deficient phenotype (Table 2). 
Based on reasonable biosynthetic principles, the condensa- 
tion of ,4HB.4 with [I-glucosamine can be initiated in two 
different ways - either initial formation of a C&--C, bond 
by an acylation or alkylation reaction. or formation of a 
Schiff base between the AHBA nitrogen and I>-glu- 
cosamine Cl aldehyde, followed by the ring closure at 
C,,-C,. MitR, one of the two hIcrA homologs might be 
involved in one of the ring-closure reactions. Interestingly, 
hlitR showed high sequence homology to the plant 
berberine bridge enzyme (BBE; 30% identity, 37% simi- 
larity) in benzophenanthridine alkaloid formation, where it 
catalyzes an unusual C-C bond formation of the berberine 
bridgehead carbon of (S)-scoulerine from the 12’methyl 
carbon of (S)-reticuline [62]. L/sing a mechanism similar to 
BBE, it is possible that MitB is involved in C&Z, bond 
formation. The decreased MC production in the rnitK dis- 
ruption mutant might be due to the existence of isoen- 
zymes (e.g. >lmc~I) that could catalyze the reaction in the 
absence of functional UitR. 
Genes for tailoring of the mitosane core 
Complete assembly of MC requires functionalization of 
several sites on the core mitosane ring system. First, com- 
plete reduction of the carbon);1 group at C-6 must occur. 
Second, hydroxylation at C-5 and C9a must proceed fol- 
lowed by methylation at C-9a. Third, amination at C-7 
must occur presumably through initial hydroxylation fol- 
lowed by transamination. Fourth, oxidation of the hydroxyl 
groups at C-5 and C-8 to form the benzoquinone are 
required. Fifth. intramolecular amination of C-l by -N-la to 
form the aziridine ring must be completed, and finally, car- 
bamoylation at C-10 completes assembly of the molecule. 
Several putative enzymes found in this cluster are candi- 
dates for these modifications and are discussed below. 
Methyla tion 
In contrast to hlC, which has an O-methyl group at C-9a, 
mitomycin A and mitomycin B also contain a C-7 O-methyl 
group, and mitomycin B, mitomycin D and porfiromycin 
have an Al’-meth>-I group on the aziridine ring (Figure 1). 
Radiolabeled precursor incorporation studies showed that 
all of the 0- and !V-methyl (but not the C-methyl) groups 
in the mitomycin molecules are derived from I,-methionine 
[22]. Typically, the methyl donor for most Cl reactions is 
S-adenosyl-1,-methionine (SAM), which can be formed 
through activation of I=methionine by ATP. Three SAhiI- 
dependent methyltransferase genes were identified in this 
cluster (encoding hIit,\I, hlitN and blmcR), all of which 
have three conserved S-adenosylmethionine- or S-adeno- 
sylhomocysteine-binding motifs [63] (Figure 3). Interest- 
ingly, database searches of hfitM and hlith (probably 
responsible for the IN: C-Ya sidechain methylation) 
revealed a group of plant 6-(23)-sterol C-methyltrans- 
ferases, but have a closer phylogenetic relationship with 
the rifamycin 0-methyltransferase (ORFlq) and ery- 
throm>Tcin 0-methyltransferase (EryG) [31,64] (Figure 4). 
In contrast, protein database searches revealed that RImcR 
is most related to other S’~~pto?n~~es antibiotic biosynthetic 
0-methyltransferases with greatest similarity to 
0-demethylpuromycin 0-methyltransferase (44% identity, 
60% similarity) from S. am/am and carminomycin 
q-O-methyltransferase from S. peuretaus [65,66]. RlmcR 
might be involved in the 0-methylation of the phenol ring 
of h/lC before oxidation to the quinone. Both mm-R and 
mifi1.f were shown to be essential for hIC biosynthesis 
because disruption of each one completely abolished MC 
production (‘fable 2). 
A SAhl-independent methyltransferase, hImcD, was also 
identified in the 4IC cluster. MmcD shares strong 
sequence homology with the magnesium-protoporphyrin 
IX monomethyl ester oxidative cyclase (34% identity, 
53% similarity) from ~Lfe~~anoJw~~eriurn fhemoaurotrop~- 
icum (GenBank accession #2622915), as well as the phos- 
phonoacetaldehyde methyltransferase from &reptom?lces 
W&UZWU~S 1671, the P-methyltransferase from Strepto- 
~~YZS hygroscvpicus [68] and the fortimicin KL methyl- 
transferase from .~~iuomonospora oliwzsterospora [69]. 
Instead of SAM, this group of methyltransferases uses 
methylcobalamine or a structurally related protopor- 
phyrin as the direct methyl donor. Although the greatest 
number of matches were made to protoporphyrin methyl- 
transferases, this enzyme is expected to have another 
function in the j,IC biosynthetic pathway as all the 0- and 
A’-methyl groups of SIC have been shown to be derived 
from SAhl-dependent methyltransferases. 
C-6 carbonyl reduction 
The C-6 methyl group was shown previously to be derived 
from the reduction of the carboxylic acid of AHBA, because 
[carboxy-‘“Cl AHBA can be efficiently, and specifically, 
incorporated into the C-6 methyl group of porfiromycin 
[ZO]. In the hIC cluster, four F420-dependent tetrahy- 
dromethanopterin (H,hIPT) reductase genes (encoding 
\IitH, hIitK, MmcI and hImcJ) and one H,hIP’T:ColLI 
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Figure 3 
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Motif I 
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Motif III Chemistry & Bology 
The three SAM-dependent methyltransferase 
conserved motifs can be found in MitM, MitN 
and MmcR. DmpM [65], TcmN [lOOI, ORF14 
131 I and EryG [10 1 I are 0-methyltransferases 
for puromycin, tetracenomycin C, rifamycin 
and erythromycin biosynthesis, respectively. 
methyltransferase gene (encoding hlmcE) are candidates 
for the C-6 carbonyl reduction. In the methanogenesis 
pathway of J4eth~nob~cterium t~er?naautat~~ph~~~?n, two 
cofactor F420-dependent H,hlPT reductases, and one 
cofactor CohI dependent methyltrdnsferase are required in 
the seven-step reduction from COz to CH,. Steps 4 to 6 
from CH-H,RIPT to CHZ-H,MPT, and CH,-H,MPT to 
CHj-CoM are catalyzed by 115, iV(‘-methylene-H,\IPT 
dehydrogenase, iV, M”-methylene-H&vIPT reductase and 
@-methyl-H,MPT:CoM methyltrdnsferase, respectively 
[70,71]. All four enzymes (!vlitH, MitK, MmcI, MmcJ) in 
this cluster showed local sequence similarity with the 
cloned F420-dependent H,hlPT reductase (42% identity, 
62% similarity in several 50 amino-acid fragments) [i&73]. 
One of these genes, mitfi was disrupted, and the mutant 
strain had an MC-deficient phenotype (Table 2). Mm& is 
notable because the deduced protein sequence contains 
two domains showing significant alignment (33% identity. 
56% similarity) to the amino terminus of H,MP’T:Cohl 
methyltransferase from ~14ef~~nobacterillm thermoautotroph- 
~~IU,V [74], and the remaining carboxyl terminus is related to 
fatty acid biosynthetic acyl carrier proteins (ACPs) [7.5,76]. 
The potential function of this ACP-like domain in MC 
biosynthesis remains unknown, as does the role of a dis- 
tinct gene (m-m&) encoding a putative ACP identified just 
upstream of mm&. Significantly, the disruption of mmcB 
resulted in total abrogation of MC production (Table 2). 
Hydroxyla t/on 
-The two putative hydroxylases (encoded by mmc;\:, mmc73 
identified in the MC cluster are candidates for catalyzing 
hydroxylation at the C-S. C-7, and C-9a positions on the 
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Figure 4 
DnrK (Sfreptomyces peucefius) 
DauK (Sfv.?pfomyces sp. strain C5) 
RdmB (Sfrepfomyces purpurascens) 
DmpM (Sfrepfomyces anulafus) 
MmcR (Streptomyces lavendulae 
TcmN (Sfreptomyces glaucescens) 
-SMT (G/y&e maw) 
ISED (Saccharomyces cerevisiae) 
ORF14 (Amycolatopsis mediterrane/) 
MitM (Sfrepfomyces lavenduiae) 
MitN (Sfrepfomyces lavendulae) 
EryG (Saccharopolyspora eryfhraea) 
Chemistry & Bnlogy i 
Sequence similarity of MitM, MitN and MmcR with other O-methyl- 
transferases (DmpM [65], TcmN [l DO], ORFl4 t311, EtyG [lOi 1, RdmB 
[102], DnrK [66], and DauK 11031) and C-methyltransferases (SMT [64], 
ESMTl [104], SMTl [105], and SE06 [106]). The dendrogram was 
constructed with the program PILEUP [95]. 
mitosane system. MmcN belongs to the cytochrome P450 
family of monooxygenases, with greatest homolog)- (37% 
identity, 56% similarity) to the two herbicide-inducible 
cytochrome P45Os (P450-SUl ‘and P450-SUZ) from 
S. gtiscolus, as well as to RapJ and RapN in the rapamycin 
biosynthetic gene cluster from S. kygroscopicu~ [33,35]. 
MmcT showed highest similarity to the tetracenomycin C 
hydroxylase (TcmG) in Streptomyces glaurescens (38% iden- 
tity, 55% similarity), with lower but significant sequence 
similarity to a group of phenol or hydroxybenzoate 
hydroxylases [77]. Genetic disruption of mmcTcompletely 
blocked MC biosynthesis (Table 2). 
Carbamoylation 
The carbamoyl group of MC is derived intact from I,-cit- 
rulline or L-arginine with carbamoyl phosphate as the incor- 
porated precursor [Zl]. In eubacteria, carbamoyl phosphate 
can be generated from L-glutamine, HCO,-, and ATP by 
the enzyme carbamopl phosphate synthetase, which is 
indispensable for pyrimidine biosynthesis. One candidate 
carbamoyl transferase gene (mm& was identified directly 
upstream of mmcT. Mm& belongs to the NodIT/CmcH 
family of O-carbamoylation enzymes, with the greatest sim- 
ilarity (35% identity, 44% similarity) to X010 from R&o- 
&m sp. [78]. Other members with significant alignment in 
this family include No10 from Braa”rkizobium jrrponirum 
[79] and NodIJ from Rhohm sp. for 6-O-carbamoylation 
of Nod factors [80], and CmcH from Nocardia lartamdurans 
and S. r/a&kg-erus for 3’-hydroxymethylcephem O-carba- 
moylation in cephamycin biosynthesis [81]. 
Discussion 
Bridging primary and secondary metabolism 
The shikimate pathway is an essential metabolic route in 
microorganisms and plants for aromatic amino-acid biosyn- 
thesis. Genes that encode the early shikimate pathway 
enzymes from various organisms ha\-e been w-e11 studied 
and are often dispersed along the chromosome as revealed 
by sequencing of complete microbial genomes [53,.54,82]. 
The finding that the ansamycin and mitomycin natural 
products are derived in part from an ammoniated shiki- 
mate pathway whose genes are clustered on the bacterial 
chromosome is a significant difference to the primary 
metabolic network, and could suggest an important evolu- 
tionary bridge leading to secondary metabolism. The lack 
of incorporation of early shikimate pathway intermediates 
into mitomycin and ansamycin metabolites indicated the 
existence and ultimate substrate specificity of the alter- 
nate ammoniated shikimate pathway enzymes. The con- 
version of aminoDAHP and aminoshikimic acid by the 
corresponding primary shikimate pathway enzymes to 
aminoDHQ and aminoDHS, respectively [Sl], however, 
suggested that substrate specificity in the primary meta- 
bolic shikimate pathway is mainly determined by the 
initial reaction step. This notion is further supported by 
the disruption results for $i and $I mutants showing 
only a minimal affecr on rifamycin production [25]. 
In addition to the absence of an aminoDAHP synthase 
gene, the organization of the AHBA biosynthetic genes in 
the hlC cluster is quite different compared to the $ 
cluster. In r;f (with the exception of r&V), all AHBA 
biosynthetic genes are found within a defined subcluster 
that are organized into a single apparent operon. In con- 
trast, almost all of the m4t/mmc-encoded AHBA genes are 
scattered within the S5 kb MC cluster. Thus, as opposed 
to the multifunctional polyketide gene clusters whose lin- 
earity of architecture reflects a precise pattern of biosyn- 
thesis, the 1\IC cluster is biochemically less transparent 
based on a similar primary analysis. Nevertheless, with a 
complete set of MC biosynthetic genes in hand it w-ill be 
possible to begin a thorough dissection of the mode of 
assembly and function of each enzyme. In addition. the 
MC cluster provides a good model for analyzing genetic 
evolution both vertically, from the primary metabolic 
shikimate pathway to the secondary shikimate pathway 
related route, and horizontally by comparing different 
groups of secondary metabolic biosynthetic clusters. 
The MC biosynthetic network 
In a typical liquid culture of S. lauendulae, MC production 
is initiated 24 h after inoculating the seed culture, reaches 
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maximum production in 2 days, and maintains drug syn- 
thesis during stationary phase for another 2 days. Com- 
pared with high-level MC resistance of the wild-type 
S. /avendul’ae (>150 pg/ml), MC production is relatively low 
(<5 pg/ml MC). The significant gap between the self-resis- 
tance and production levels makes it possible to improve 
drug production through genetic engineering. In this work? 
disruption of either the candidate repressor gene (mmcW) 
or the downstream mmcX (encoding an unknown mem- 
brane protein) in the MC cluster resulted in a several-fold 
increase in MC production. The existence of a repressor 
gene(s) is not uncommon in Streptomn~~es antibiotic biosyn- 
thetic gene clusters. Previous examples include mmyR from 
the methylenomycin cluster [83], act(l-ofl in the acti- 
norhodin cluster [84], jaa’R(Z) in jadomycin biosynthesis 
[85] and AvQ in the daunorubicin cluster [86]. Disruption 
ofjadR [20] and mmyR also resulted in increased levels of 
the corresponding antibiotics [83,8S]. 
In order to avoid autotoxicity, drug-producing microorgan- 
isms must evolve self-protection systems. Currently, three 
types of self-protection mechanisms have been identified 
in S. lavenchlae for MC resistance. including MC binding 
(Mrd), efflux (Met) and reversing MC reductive activation 
(McrA). In principle, resistance genes must be expressed 
before drug formation. In this respect, it is interesting to 
note the linkage of the MC resistance genes with putative 
regulatory genes. Expression of the high-level resistance 
gene mcrA has been demonstrated to be regulated by the 
downstream gene mcrB, which is presumably cotranscribed 
with mcril [27]. Though the function of the McrA homolog 
MitR in the MC cluster remains unknown, mitR is also fol- 
lowed by a cotranscribed regulatory gene (m&2), and the 
putative MC translocase gene, met, is followed by the 
repressor gene, mmcW. Genetic linkage of membrane trans- 
porter/resistance and repressor genes have been described 
in a number of cases, including tetA/tetR in tetracycline 
resistance [87], tcmA/tcmR in tetracenomycin C resistance 
[88]. actZZ-o$?/actZZ-o@ in actinorhodin resistance [84], 
and the qacA/qacR pair for multidrug resistance in S. aureells 
[89]. The specific regulatory role that MmcW plays in MC 
resistance and biosynthesis remains to be elucidated. 
Significance 
Although mitomycin C (MC) was first isolated more 
than 40 years ago and has been used in anticancer 
chemotherapy since the 196Os, the mechanistic details 
and order of its biosynthesis has remained unclear. This 
work represents a complete characterization of the gene 
cluster in Streptomyces lavendulae responsible for MC 
biosynthesis. Our results are clearly consistent with pre- 
cursor incorporation studies gathered in the 1970~3, 
showing that MC is biosynthetically derived from U-glu- 
cosamine, L-methionine, carbamoyl phosphate and 
AHBA, and also support the use of the variant de novo 
shikimate pathway leading to AHBA [21,511. Many, if 
not all of the genes responsible for the formation of the 
mitosane and aziridine rings are located within the 
boundary of the 55 kb MC cluster. These genes are of 
special interest because their functions are poorly under- 
stood and they might be useful as probes for identifying 
related natural-product biosynthetic genes from other 
microorganisms and plants. 
The cloned genes presented here provide a key starting 
point for future molecular genetic and biochemical 
studies on MC biosynthesis and natural-product assem- 
bly. The advantage of having this information has 
already been demonstrated through genetic disruption of 
the candidate repressor gene (mmcW) that provided a 
several-fold increase in MC production. In addition, 
expression and disruption of selected genes should be 
useful for engineering the biosynthesis of clinically valu- 
able mitomycin analogues, as well as more complex 
hybrid natural-product systems. Finally, the MC resis- 
tance and regulatory genes identified in this cluster will 
provide important insight into the MC biosynthetic and 
regulatory network in S. lavendulae. 
Materials and methods 
Bacterial strains and cloning vectors 
S. hendulae NRRL2564 was used as the source strain for cosmid 
library construction and the creation of gene-disruption mutants. E. co/i 
DH5c( was used as the host strain for constructing the library and sub- 
sequent DNA manipulation. E. co/i strain S17-1 [90] served as the con- 
jugative host for introducing foreign DNA into S. /wend&e. The 
cosmid library was constructed with the E. co/+Streptomyces shuttle 
vector pNJ1 1911, and pUCll9 was routinely used as a vector for sub- 
cloning and sequencing. The conjugative E. co/i-Streptomyces shuttle 
vector pKC1 139 1921 was used for gene disruption in S. /wend&e. 
DNA manipulation 
Standard in vitro techniques were used for DNA manipulation [93]. 
S. lavendulae genomic DNA was harvested using standard procedures 
[94]. A library of size-fractionated genomic DNA in pNJ1 [91] was 
screened with the rifamycin AHBA synthase (rifK) gene probe from 
Amycolatopsis mediferranei [301. Through subsequent cosmid 
walking, a contiguous 120 kb region of S. lavendulae chromosomal 
DNA containing the putative MC biosynthetic genes was mapped. Ml 3 
forward and reverse primers were used for sequencing (Gibco BRL). 
To accomplish this, individual fragments of less than 5 kb were sub- 
cloned into pUC1 19 and serial deletion subclones were generated 
using the exonuclease Ill Erase-a Base System (Promega). 
DNA sequencing and analysis 
Automatic DNA sequencing was carried out with the ABI PRISMTM 
Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosys- 
terns), and analyzed on an Applied Biosystems model 377 DNA 
Sequencer at the University of Minnesota Advanced Genetic Analysis 
Center. Both DNA strands were sequenced redundantly a minimum of 
three times. Sequence compilation was performed with MacVector 
(Oxford Molecular Group) and GeneWorks (Oxford Molecular Group) 
software, and sequence homology analysis was accomplished using 
BLAST [95] and GCG programs [96]. 
Disruption mutant construction 
A 1.4 kb ApaLl-HindlIt fragment from pFD666 [971 containing the 
aphll gene for kanamycin resistance was routinely used as the selec- 
tion marker for the creation of gene-disruption constructs. The target 
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genes were subcloned into pUCll9, cut at a unique internal restriction 
site, blunt-ended, and ligated with the end-blunted selection marker. 
The inserts were then transferred from pUC1 1 g to pKCll39, and con- 
jugated into wild-type S. lavendulae [2gl. Transconjugants were 
selected on AS1 plates [g8], overlaid with apramycin, kanamycin and 
nalidixic acid followed by propagation on R5T plates at 37°C for 
several generations. Disruption mutants were selected based on the 
phenotype changing from apramycin- and kanamycin-resistant to 
apramycin-sensitive and kanamycin-resistant. Replacement of the chro- 
mosomal copy of the target gene with the disrupted plasmid-borne 
copy was confirmed by Southern blot hybridization. 
Mitomycin C analysis 
MC production was evaluated using 3-day cultures in Nishikohri media 
[99]. The culture broth was extracted twice with equal volumes of ethyl 
acetate. After removing the chemical solvent by vacuum, the crude broth 
extract was dissolved in 50% methanol and 50% 50 mM pH 7.2 Tris 
buffer and monitored by HPLC (C,, reverse phase column) at 363 nm. A 
continuous methanol gradient from 20% to 60% in methanol/50 mM 
pH 7.2 Tris buffer system over 24 min was employed to resolve MC from 
other crude extract components. A 90% CHCl,/lO% MeOH solvent 
system was used to resolve and detect MC on TLC plates. 
Accession numbers 
The entire sequence reported here, together with the two previously 
submitted loci [29,43], have been deposited in the GenBank database 
under the accession number AF127374. 
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